| Literature DB >> 34925403 |
Peng Shi1,2,3, Wei Hua1, Yin Min Htwe2,3, Dapeng Zhang2,3, Jun Li1, Yong Wang2,3.
Abstract
Abscisic acid plays an important role in fruit development. However, the effect of ABA on fatty acid biosynthesis in oil palm is still unknown. In this study, ABA treatments (CK, A1-A4) were applied to oil palm fruit at 16 WAP (weeks after pollination), and fatty acids in the mesocarp at 24 WAP were analyzed by GC-MS. Results showed that linoleic acid content under treatment A2 (20 μM ABA) was significantly higher (slightly increased by 8.33%) than the control. Therefore, mesocarp samples of A2, and the control at 16, 20, and 24 WAP was sampled for RNA-Seq. KEGG pathway enrichment analysis showed that 43 genes were differentially expressed in the fatty acid biosynthesis pathway, of which expression of EgFAD2 (unigene 105050201) under 20 μM ABA treatment was 1.84-fold higher than in the control at 20 WAP. Further sequence analysis found that unigene 105050201 had more ABA-responsive elements (ABRE), complete conserved domains, and a C-terminal signaling motif among two FAD2 copies. Furthermore, WGCNA and correlation analysis showed co-expression of EgFAD2 (unigene 105050201) with transcription factors (TFs) (WRI1, AP2-EREBP, bZIP, bHLH, C2C2-Dof, MYB, NAC, and WRKY), ABA signaling genes (PYR, PP2C, SnRK, and ABI5), and other genes involved in fatty acid biosynthesis (FATA, FATB, LACS, SAD, Oleosins, and so on). These results indicated that ABA treatment promoted the expression of FAD2 and other genes involved in fatty acid biosynthesis, which possibly resulted in the accumulation of linoleic acid. This study will be helpful for understanding the possible mechanisms through which ABA affects fatty acid biosynthesis and their accumulation in the mesocarp of oil palm.Entities:
Keywords: ABRE motif; FAD2; abscisic acid; linoleic acid; oil palm
Year: 2021 PMID: 34925403 PMCID: PMC8678531 DOI: 10.3389/fpls.2021.748130
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Treatment and sampling information.
| Treatment | CK | A1 | A2 | A3 | A4 |
| ABA concentration | 0 μM | 10 μM | 20 μM | 50 μM | 200 μM |
| Fatty acid composition measure | CK_5(24 WAP) | A1_5(24 WAP) | A2_5(24 WAP) | A3_5(24 WAP) | A4_5(24 WAP) |
| RNA-Seq | CK_1(16WAP), | A2_1(16WAP), |
FIGURE 1Heat map of fatty acid composition content after different exogenous ABA treatments. CK, treatment with 0 μM ABA; A1, treatment with 10 μM ABA; A2, treatment with 20 μM ABA; A3, treatment with 50 μM ABA; A4, treatment with 200 μM ABA. Each colored cell on the map corresponds to a concentration value.
Categorization and a summary of abundance of RNA-seq reads and genes in 18 libraries.
| Sample | Total raw reads (M) | Total clean reads (M) | Total clean bases (Gb) | Clean reads Q20 (%) | Clean reads Q30 (%) | Clean reads ratio (%) | Total genome mapping (%) | Uniquely genome mapping (%) | Total gene mapping (%) | Uniquely gene mapping (%) |
| A2_1A | 49.08 | 43.45 | 6.52 | 94.47 | 88.22 | 88.52 | 82.62 | 38.42 | 75.73 | 60.63 |
| A2_1B | 49.08 | 43.30 | 6.50 | 94.34 | 87.94 | 88.23 | 82.40 | 37.87 | 76.05 | 61.10 |
| A2_1C | 49.08 | 43.45 | 6.52 | 94.43 | 88.13 | 88.52 | 82.22 | 37.81 | 75.28 | 60.33 |
| A2_3A | 47.33 | 42.04 | 6.31 | 94.41 | 88.09 | 88.83 | 82.80 | 38.64 | 78.98 | 63.14 |
| A2_3B | 49.08 | 43.48 | 6.52 | 94.26 | 87.77 | 88.60 | 82.60 | 37.36 | 79.62 | 63.84 |
| A2_3C | 47.33 | 42.01 | 6.30 | 94.34 | 87.96 | 88.77 | 82.60 | 37.74 | 79.13 | 63.27 |
| A2_5A | 50.83 | 43.42 | 6.51 | 94.26 | 87.89 | 85.42 | 80.34 | 36.93 | 75.98 | 59.67 |
| A2_5B | 49.08 | 43.35 | 6.50 | 94.31 | 87.91 | 88.33 | 81.78 | 36.95 | 77.74 | 60.71 |
| A2_5C | 49.08 | 43.28 | 6.49 | 94.38 | 88.03 | 88.19 | 81.61 | 37.35 | 77.11 | 60.09 |
| CK_1A | 49.08 | 43.45 | 6.52 | 94.71 | 88.72 | 88.53 | 82.95 | 39.24 | 76.00 | 60.57 |
| CK_1B | 49.08 | 43.10 | 6.46 | 94.27 | 87.81 | 87.82 | 81.83 | 37.03 | 75.42 | 60.23 |
| CK_1C | 47.33 | 41.95 | 6.29 | 94.26 | 87.75 | 88.63 | 81.76 | 37.03 | 74.42 | 59.49 |
| CK_3A | 47.33 | 42.10 | 6.32 | 94.61 | 88.51 | 88.96 | 82.96 | 39.55 | 77.84 | 61.73 |
| CK_3B | 49.08 | 43.36 | 6.50 | 94.27 | 87.75 | 88.35 | 82.43 | 37.47 | 77.87 | 62.04 |
| CK_3C | 42.16 | 37.59 | 5.64 | 94.37 | 87.97 | 89.15 | 82.50 | 37.84 | 77.60 | 61.71 |
| CK_5A | 49.08 | 43.45 | 6.52 | 94.53 | 88.36 | 88.53 | 83.31 | 39.30 | 78.12 | 63.06 |
| CK_5B | 47.33 | 42.22 | 6.33 | 94.30 | 87.83 | 89.22 | 83.31 | 38.06 | 78.47 | 63.47 |
| CK_5C | 47.33 | 42.05 | 6.31 | 94.40 | 88.05 | 88.85 | 82.91 | 38.39 | 77.31 | 62.28 |
FIGURE 2Transcriptome at 0, 4, and 8 weeks after treatment with 0 and 20 μM ABA. (A) Principal component analysis of six samples. (B) Pearson correlation coefficient of gene expression levels between samples. (C) Distribution of gene expression levels in each sample. The x-axis shows the sample name, and the y-axis shows log10 [FPKM (fragments per kilobase of exon model per million mapped reads) + 1]. The box plot for each region corresponds to five statistics (upper to lower, upper quartile, median, and lower quartile, lower limit, where the upper and lower limits do not take outliers into account).
FIGURE 3A summary of DEGs between CK and A2. (A) Number of DEGs. (B) The Venn diagram of DEGs between CK and A2.
FIGURE 4The transcriptional model of fatty acid biosynthesis in developing oil palm mesocarp. The 18 squares in each horizontal row correspond to three replicates of three stages (16 WAP, 20 WAP, and 24 WAP) in CK and A2. G-3-P, glycerol-3-phosphate; LPA, 1-acylglycerol-3P; PA, phosphatidic acid; DAG, 1,2-diacylglycerol; and TAG, triacylglycerol.
FIGURE 5FAD2 expression in CK and A2. **Represents significance at p < 0.01. CK_1: 16 WAP with 0 μM ABA; CK_3: 20 WAP with 0 μM ABA; CK_5: 24 WAP with 0 μM ABA; A2_1: 16 WAP with 20 μM ABA; A2_3: 20 WAP with 20 μM ABA; A2_5: 24 WAP with 20 μM ABA.
ABRE cis-acting element prediction of FAD2.
| Gene ID | Sequence | Position | Matrix Score | Strand | Organism |
| LOC105050201 | GCAACGTGTC | 755 | 9 | + |
|
| CACGTG | 757 | 6 | + |
| |
| ACGTG | 758 | 5 | + |
| |
| CACGTG | 807 | 6 | + |
| |
| ACGTG | 808 | 5 | + |
| |
| ACGTG | 1,699 | 5 | + |
| |
| LOC105061227 | CACGTG | 183 | 6 | + |
|
| ACGTG | 184 | 5 | + |
| |
| GCAACGTGTC | 376 | 9 | + |
| |
| AACCCGG | 705 | 7 | - |
| |
| CACGTG | 1,776 | 6 | - |
| |
| ACGTG | 1,777 | 5 | + |
| |
| CACGTG | 2,767 | 6 | - |
| |
| ACGTG | 2,768 | 5 | + |
|
FIGURE 6An alignment view of two FAD2 copies. Red blocks represent histidine-rich domains.
FIGURE 7Correlation network of genes involving fatty acid biosynthesis, ABA-signaling transduction, and transcriptional factors between CK and A2 during mesocarp development. Ellipses, diamonds, and rectangles, respectively, represent genes involving fatty acid biosynthesis, ABA-signaling transduction, and transcriptional factors. Node fill color is according to log2FC of FPKM value in CK_3 vs. A2_3 from blue to red; TFs, transcriptional factors; PYR, pyrabactin resistance; PP2C, type 2C protein phosphatases; SnRK, Snf1-related protein kinase; ABI5, ABA insensitive 5; AP2-EREBP, APETALA2-ethylene responsive element-binding protein; bZIP, basic leucine zipper; bHLH, basic helix loop helix; C2C2-Dof, downstream of FGFR; MYB, myeloblastosis; NAC, nascent polypeptide-associated complex; WRKY, WRKY transcriptional factor; WRI1, WRINKLED1; KASIII, 3-ketoacyl-ACP synthase III; GPAT, glycerol-3-phosphate acyltransferase; FATA, fatty acid acyl-ACP thioesterase A; PDH-E1-β, subunit b of E1 component of PDH complex; PDH-E1-α, subunit α of E1 component of PDH complex; ACC/CTα, carboxyltransferase a-subunit of heteromeric ACCase; ACC/BCCP, biotin carboxyl-carrier protein of heteromeric ACCase; PDH(E2), E2 component of PDH complex; EAR, enoyl-ACP reductase; LACS, long-chain acyl-CoA synthetase; FAD2, ω-6 desaturase; KASII, 3-ketoacyl-ACP synthase II; FATB, fatty acid acyl-ACP thioesterase B; DGAT2, diacylglycerol acyltransferase 2, HAD, 3-hydroxyacyl-ACP dehydratase; MAT, malonyl-CoA: ACP transacylase; ACC/BC, biotin carboxylase subunit of heteromeric acetyl-CoA carboxylase; KAR, 3-ketoacyl-ACP reductase; DGAT1, diacylglycerol acyltransferase 1; CPT, CDP-choline: DAG cholinephosphotransferase; FAD3, ω-3 desaturase; PDAT, phospholipid: diacylglycerol acyltransferase; SAD, stearoyl-ACP desaturase; PAP, phosphatic acid phosphohydrolase.
FIGURE 8An speculative regulation mechanism of ABA-promoting linoleic acid biosynthesis in oil palm mesocarp.